Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sook Kyoung | - |
dc.contributor.author | Pak, Hui-Nam | - |
dc.contributor.author | Park, Jae Hyung | - |
dc.contributor.author | Ko, Kyoung Jeong | - |
dc.contributor.author | Lee, Jihei Sara | - |
dc.contributor.author | Choi, Jong Il | - |
dc.contributor.author | Choi, Dong Hoon | - |
dc.contributor.author | Kim, Young-Hoon | - |
dc.date.accessioned | 2021-09-08T11:08:50Z | - |
dc.date.available | 2021-09-08T11:08:50Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2009-12 | - |
dc.identifier.issn | 1099-5129 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/118849 | - |
dc.description.abstract | Although electrical cardioversion (CV) is effective in restoring sinus rhythm in patients with atrial fibrillation (AF), AF frequently recurs in spite of antiarrhythmic medications. We investigated the predictors of failed CV and AF recurrence after successful CV. In 81 patients (M:F = 63:18, 59.1 +/- 10.5 years old) with AF who underwent CV, clinical, image, and CV findings (energy requirement, immediate recurrence of AF < 15 min), and pre-CV serological markers were evaluated. Results: (i) During 13.1 +/- 10.6 months of follow-up, 8.6% (7/81) showed failed CV, 59.26% (48/81) showed AF recurrence, and 32.1% (26/81) remained in sinus rhythm (no recurrence). (ii) Failed CV showed higher plasma levels of transforming growth factor (TGF)-beta (P = 0.0260) than those with successful CV. (iii) Patients with AF recurrence were older (60.4 +/- 9.0 years old vs. 55.3 +/- 12.5years old, P = 0.0220), had a higher incidence of spontaneous echo contrast (SEC; 68.1 vs. 40.0%, P = 0.0106), a lower prescription rate of angiotensin-converting enzyme inhibitor (ACE-I)/angiotensin receptor blocker (ARB; 27.0 vs. 50.0%, P = 0.0248) or spironolactone (0.0 vs. 19.2%, P = 0.0007), and lower plasma levels of stromal cell-derived factor (SDF)-1 alpha (P = 0.0105). Post-CV recurrence commonly occurs in patients with age > 60 years, SEC, under-utilization of ACE-I/ARB or spironolactone, and low plasma levels of SDF-1 alpha. High plasma level of TGF-beta predicts failed CV. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.subject | HEMATOPOIETIC PROGENITOR CELLS | - |
dc.subject | C-REACTIVE PROTEIN | - |
dc.subject | SINUS RHYTHM | - |
dc.subject | TIME-COURSE | - |
dc.subject | PERSISTENT | - |
dc.subject | AMIODARONE | - |
dc.subject | PREVENTION | - |
dc.subject | INFLAMMATION | - |
dc.subject | ABLATION | - |
dc.subject | EFFICACY | - |
dc.title | Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Jong Il | - |
dc.contributor.affiliatedAuthor | Kim, Young-Hoon | - |
dc.identifier.doi | 10.1093/europace/eup321 | - |
dc.identifier.scopusid | 2-s2.0-71449087318 | - |
dc.identifier.wosid | 000272179500012 | - |
dc.identifier.bibliographicCitation | EUROPACE, v.11, no.12, pp.1632 - 1638 | - |
dc.relation.isPartOf | EUROPACE | - |
dc.citation.title | EUROPACE | - |
dc.citation.volume | 11 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1632 | - |
dc.citation.endPage | 1638 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | HEMATOPOIETIC PROGENITOR CELLS | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | SINUS RHYTHM | - |
dc.subject.keywordPlus | TIME-COURSE | - |
dc.subject.keywordPlus | PERSISTENT | - |
dc.subject.keywordPlus | AMIODARONE | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | ABLATION | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Electrical cardioversion | - |
dc.subject.keywordAuthor | Recurrence | - |
dc.subject.keywordAuthor | Predictor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.